» Articles » PMID: 1271013

Successful Treatment of Enterovirus-infected Mice by 2-(alpha-hydroxybenzyl)-benzimidazole and Guanidine

Overview
Journal J Exp Med
Date 1976 Jun 1
PMID 1271013
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Echo virus 9- or Coxsackie A 9-infected newborn mice are protected from paralysis and death by combined treatment with nontoxic concentrations of HBB plus guanidine. HBB alone also protects Coxsackie A 9, but not echo virus 9-infected animals, whereas guanidine alone is ineffective in either case. Protection is due to inhibition of virus multiplication via the antiviral activity of these selective inhibitors. Treatment must be begun at the latest 48 h after virus inoculation. 3 days of treatment are sufficient if started at the time of virus inoculation. Failure of protection after treatment with one compound alone is not due to rapid development of drug-resistant virus mutants. Infected, successfully treated mice may develop a solid immunity.

Citing Articles

Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice.

Hurst B, Evans W, Smee D, Van Wettere A, Bart Tarbet E Virology. 2018; 526:146-154.

PMID: 30390563 PMC: 6309259. DOI: 10.1016/j.virol.2018.10.014.


Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.

Smee D, Evans W, Nicolaou K, Bart Tarbet E, Day C Antiviral Res. 2016; 131:61-5.

PMID: 27063860 PMC: 5100981. DOI: 10.1016/j.antiviral.2016.04.003.


The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.

De Palma A, Heggermont W, Lanke K, Coutard B, Bergmann M, Monforte A J Virol. 2008; 82(10):4720-30.

PMID: 18337578 PMC: 2346740. DOI: 10.1128/JVI.01338-07.


Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives.

Shimizu H, Agoh M, Agoh Y, Yoshida H, Yoshii K, Yoneyama T J Virol. 2001; 74(9):4146-54.

PMID: 10756027 PMC: 111929. DOI: 10.1128/jvi.74.9.4146-4154.2000.


Picornavirus inhibitors.

Carrasco L Pharmacol Ther. 1994; 64(2):215-90.

PMID: 7533301 PMC: 7133639. DOI: 10.1016/0163-7258(94)90040-x.


References
1.
Eggers H, Tamm I . Antiviral chemotherapy. Annu Rev Pharmacol. 1966; 6:231-50. DOI: 10.1146/annurev.pa.06.040166.001311. View

2.
HOLLINSHEAD A, Smith P . Effects of certain purines and related compounds on virus propagation. J Pharmacol Exp Ther. 1958; 123(1):54-62. View

3.
Eggers H, Tamm I . 2,(alpha-hydroxybenzyl)-benzimidazole (HBB) as an aid in virus classification. Virology. 1961; 13:545-6. DOI: 10.1016/0042-6822(61)90285-9. View

4.
Eggers H, Tamm I . Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole. J Exp Med. 1961; 113:657-82. PMC: 2137377. DOI: 10.1084/jem.113.4.657. View

5.
Melnick J, Crowther D, BARRERA-ORO J . Rapid development of drug-resistant mutants of poliovirus. Science. 1961; 134(3478):557. DOI: 10.1126/science.134.3478.557. View